CATHERINE HANNEMAN: Open Payments
NPI 1013791706 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,940 in 134 payments from 37 companies in 2025. Trend: 2023 $1,575 · 2024 $3,265 · 2025 $2,940
Food & beverage: $2,940
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $787 |
| GlaxoSmithKline, LLC. | 12 | $322 |
| Janssen Biotech, Inc. | 11 | $271 |
| Novartis Pharmaceuticals Corporation | 8 | $196 |
| Daiichi Sankyo Inc. | 6 | $157 |
| Merck Sharp & Dohme LLC | 5 | $144 |
| Amgen Inc. | 4 | $97 |
| Mallinckrodt Hospital Products Inc. | 4 | $91 |
| PFIZER INC. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
Products named: RINVOQ, SKYRIZI, BENLYSTA, TREMFYA, Enhertu, ACTHAR, XELJANZ, SCEMBLIX.
Industry payments across GA — which companies pay providers there.
